PHARMAZEUTISCHE KOMBINATIONEN

Patent europeic · EP2925366 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2925366
Numer da la dumonda
EP13802815
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
26-11-2013
Publitgà
07-10-2015
Concedì
21-02-2018
La protecziun finescha il pli tard
25-11-2033
Proxima taxa annuala scadenta
30-11-2026
Classas IPC
A61K 45/06 (2006.01)
A61K 31/517 (2006.01)
A61K 31/4184 (2006.01)
A61P 35/00 (2006.01)
Prioritad
US 201261731174 P 29.11.2012
US 201261731555 P 30.11.2012
US 201361755520 P 23.01.2013
Dumonda PCT
PCT/US2013/071852 26.11.2013
Publicaziun PCT
WO2014/085381 05.06.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-12-2025

    Midada

    Published in Swissreg on 01.12.2025

  2. 01-12-2024

    Midada

    Published in Swissreg on 01.12.2024

  3. 01-12-2023

    Midada

    Published in Swissreg on 01.12.2023

  4. 01-12-2022

    Midada

    Published in Swissreg on 01.12.2022

  5. 21-02-2018

    Concedì

    Published in Swissreg on 21.02.2018

Partidas

Possessur

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventur

PORTER, Dale

Cambridge, Massachusetts 02139, US

EMERY, Caroline

Cambridge, Massachusetts 02139, US

TAN, Lujian

Cambridge, Massachusetts 02139, US

YERRAMILLI-RAO, Padmaja

Cambridge, Massachusetts 02139, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.